First leukemia patient dosed with SMART101
Smart Immune has announced that the first adult leukemia patient has been dosed with SMART101,…
January 24, 2023 - 2 minutes
Blood cancer
First CAR-T technology trial for patients with T-cell leukemia subtype authorized
The Spanish Agency of Medicines and Medical Products (AEMPS) has approved the CARxALL clinical trial…
December 22, 2022 - 4 minutes
Ebvallo approval ushers in off-the-shelf T-cell immunotherapies
Patient-derived CAR-T immunotherapies have dominated the cancer immunotherapy space over the last decade. The EU…
December 20, 2022 - 6 minutes
Sponsored
by Champions Oncology
Deciphering blood cancer complexity with multi-omics and patient-relevant disease models
A new case of blood cancer gets diagnosed approximately every three minutes in Western countries.…
December 5, 2022 - 7 minutes
Estrella and TradeUP merge to become publicly traded company
Estrella Biopharma, Inc. and TradeUP Acquisition Corp. have entered into a definitive business combination agreement…
October 3, 2022 - 3 minutes
Scribe Therapeutics enters into agreement with Sanofi for use of its CRISPR technologies
Scribe Therapeutics has entered into an agreement with Sanofi which will allow Sanofi use of…
September 28, 2022 - 2 minutes
Positive results for drug combination used to treat rare blood cancer
Exploratory analysis of anti-cancer drug, navitoclax, combined with ruxolitinib - a medication for the treatment…
July 18, 2022 - 3 minutes
AstraZeneca adds to its treatments for blood cancer with $100M deal
AstraZeneca announced today (July 5) it has agreed to buy a company working on a…
July 5, 2022 - 2 minutes
Sponsored
by Takara Bio
Combination Therapies: Opportunities for Improved CAR-T Cell Therapy?
Chimeric antigen receptor (CAR) cell therapy offers hope where other cancer therapies have failed. However,…
March 10, 2022 - 6 minutes
Gene-Edited T Cell Therapy Players Battle Safety Doubts
Confidence in gene-edited T cell therapies from donor cells has faltered as Allogene Therapeutics paused…
October 22, 2021 - 5 minutes
A Cure for Cancer? How CAR-T Cell Therapy is Revolutionizing Oncology
CAR-T therapy has been hailed as a cure for cancer, but what really is this…
October 11, 2021 - 10 minutes
Update: US District Court Rules Against MorphoSys’ Cancer Immunotherapy Patents
Update (01/02/2019): MorphoSys has agreed to end its long-running legal battle with Genmab and Janssen, after…
January 28, 2019 - 3 minutes
